Investigators from Cedars-Sinai Cancer, working in collaboration with colleagues in Colorado and the Netherlands, have identified a specific type of bladder cancer most likely to resist first-line treatment. Their study, ...
May 24, 2023
0
40
Urinating more frequently and in lower volumes can be a sign of overactive bladder, according to physiologists from Beth Israel Deaconess Medical Center and Harvard Medical School in Boston. Researchers investigated how the ...
Sep 9, 2022
0
14
Physiologists at the University of Nevada, Reno have identified two ion channels necessary for urine to flow from the kidneys to the ureters. A calcium-activated chloride channel and a voltage-dependent calcium channel are ...
Sep 1, 2022
0
2
A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects. Results in mouse models and human cells show ...
Aug 22, 2022
0
29
Cancer is the third most common cause of death in people with spinal cord injury (SCI), with bladder cancer being the second most common cancer after lung cancer. It is not uncommon for bladder cancer in SCI patients to be ...
Aug 22, 2022
0
15
June is Men's Health Month, which makes this a good time to learn more about the benefits of Kegels for men.
Jun 21, 2022
0
6
A team of researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), have shown that they can use methylation patterns in cell-free DNA (cfDNA) extracted from ...
May 27, 2022
0
2
A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin. Although clinical studies would be needed to determine ...
Apr 4, 2022
0
2
Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancerinvestigators. ...
Mar 28, 2022
0
88
Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in patients with muscle-invasive bladder cancer (MIBC) not eligible for cisplatin chemotherapy. The data is from Cohort ...
Feb 14, 2022
0
24
